Loading data
MRCYNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 983.62 m USD | 912.02 m USD | 835.28 m USD | 973.88 m USD | 988.2 m USD |
| Cost of revenue | 702.46 m USD | 657.53 m USD | 639.37 m USD | 657.15 m USD | 593.24 m USD |
| Gross profit | 281.17 m USD | 254.49 m USD | 195.9 m USD | 316.73 m USD | 394.96 m USD |
| Research and development expense | 59.74 m USD | 67.65 m USD | 101.33 m USD | 108.8 m USD | 107.17 m USD |
| Selling, general and administrative expense | 175.03 m USD | 154.41 m USD | 166.79 m USD | 160.64 m USD | 157.04 m USD |
| Operating profit | 280 k USD | -19.63 m USD | -147.75 m USD | -21.69 m USD | 31.61 m USD |
| Interest expense | 29.59 m USD | 33.43 m USD | 35.02 m USD | 25.16 m USD | 5.81 m USD |
| Profit before tax | -28.89 m USD | -50.42 m USD | -189.28 m USD | -48.54 m USD | 18.4 m USD |
| Income tax expense | 784 k USD | -12.52 m USD | -51.64 m USD | -20.21 m USD | 7.12 m USD |
| Net income (reported basis) | -29.7 m USD | -37.9 m USD | -137.6 m USD | -28.3 m USD | 11.3 m USD |
| Basic earnings per share | -0.5 USD/share | -0.65 USD/share | -2.38 USD/share | -0.5 USD/share | 0.2 USD/share |
| Diluted earnings per share | -0.5 USD/share | -0.65 USD/share | -2.38 USD/share | -0.5 USD/share | 0.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.